Literature DB >> 33109601

Depression in individuals who subsequently develop inflammatory bowel disease: a population-based nested case-control study.

Jonathan Blackwell1, Sonia Saxena2, Irene Petersen3,4, Matthew Hotopf5,6, Hanna Creese2, Alex Bottle2,7, Christopher Alexakis8, Richard C Pollok9,10.   

Abstract

OBJECTIVE: Depression is a potential risk factor for developing IBD. This association may be related to GI symptoms occurring before diagnosis. We aimed to determine whether depression, adjusted for pre-existing GI symptoms, is associated with subsequent IBD.
DESIGN: We conducted a nested case-control study using the Clinical Practice Research Datalink identifying incident cases of UC and Crohn's disease (CD) from 1998 to 2016. Controls without IBD were matched for age and sex. We measured exposure to prevalent depression 4.5-5.5 years before IBD diagnosis. We created two sub-groups with prevalent depression based on whether individuals had reported GI symptoms before the onset of depression. We used conditional logistic regression to derive ORs for the risk of IBD depending on depression status.
RESULTS: We identified 10 829 UC cases, 4531 CD cases and 15 360 controls. There was an excess of prevalent depression 5 years before IBD diagnosis relative to controls (UC: 3.7% vs 2.7%, CD 3.7% vs 2.9%). Individuals with GI symptoms prior to the diagnosis of depression had increased adjusted risks of developing UC and CD compared with those without depression (UC: OR 1.47, 95% CI 1.21 to 1.79; CD: OR 1.41, 95% CI 1.04 to 1.92). Individuals with depression alone had similar risks of UC and CD to those without depression (UC: OR 1.13, 95% CI 0.99 to 1.29; CD: OR 1.12, 95% CI 0.91 to 1.38).
CONCLUSIONS: Depression, in the absence of prior GI symptoms, is not associated with subsequent development of IBD. However, depression with GI symptoms should prompt investigation for IBD. © Author(s) (or their employer(s)) 2021. No commercial re-use. See rights and permissions. Published by BMJ.

Entities:  

Keywords:  crohn's disease; inflammatory bowel disease; psychophysiology; psychosomatic medicine; ulcerative colitis

Mesh:

Year:  2020        PMID: 33109601     DOI: 10.1136/gutjnl-2020-322308

Source DB:  PubMed          Journal:  Gut        ISSN: 0017-5749            Impact factor:   23.059


  6 in total

Review 1.  Depression and anxiety in inflammatory bowel disease: epidemiology, mechanisms and treatment.

Authors:  Tania H Bisgaard; Kristine H Allin; Laurie Keefer; Ashwin N Ananthakrishnan; Tine Jess
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2022-06-22       Impact factor: 46.802

Review 2.  Therapeutic Potential of Vagus Nerve Stimulation for Inflammatory Bowel Diseases.

Authors:  Bruno Bonaz; Valérie Sinniger; Sonia Pellissier
Journal:  Front Neurosci       Date:  2021-03-22       Impact factor: 4.677

3.  Depression and anxiety in patients with active ulcerative colitis: crosstalk of gut microbiota, metabolomics and proteomics.

Authors:  Xiaomin Yuan; Biqing Chen; Zhenglan Duan; Ziqian Xia; Yang Ding; Tuo Chen; Huize Liu; Baosheng Wang; Bolin Yang; Xiaoyong Wang; Shijia Liu; Jin-Yong Zhou; Yajun Liu; Qiong Wang; Zhaofeng Shen; Jun Xiao; Hongtao Shang; Weiwei Liu; Guoping Shi; Lei Zhu; Yugen Chen
Journal:  Gut Microbes       Date:  2021 Jan-Dec

4.  Antidepressant medication use in Inflammatory Bowel Disease: a nationally representative population-based study.

Authors:  Nishani Jayasooriya; Jonathan Blackwell; Sonia Saxena; Alex Bottle; Irene Petersen; Hanna Creese; Matthew Hotopf; Richard C G Pollok
Journal:  Aliment Pharmacol Ther       Date:  2022-03-04       Impact factor: 9.524

5.  Depression and fatigue in active IBD from a microbiome perspective-a Bayesian approach to faecal metagenomics.

Authors:  Anne Kerstin Thomann; Torsten Wüstenberg; Jakob Wirbel; Laura-Louise Knoedler; Philipp Arthur Thomann; Georg Zeller; Matthias Philip Ebert; Stefanie Lis; Wolfgang Reindl
Journal:  BMC Med       Date:  2022-10-17       Impact factor: 11.150

6.  Total Flavone of Abelmoschus manihot Ameliorates Stress-Induced Microbial Alterations Drive Intestinal Barrier Injury in DSS Colitis.

Authors:  Rong Wang; Tuo Chen; Qiong Wang; Xiao-Min Yuan; Zheng-Lan Duan; Ze-Yu Feng; Yang Ding; Fan Bu; Guo-Ping Shi; Yu-Gen Chen
Journal:  Drug Des Devel Ther       Date:  2021-07-08       Impact factor: 4.162

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.